ONC Q2 2025 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$33B

Q2 2025 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$1.3B+41.6% YoY

Gross Profit

$1.2B87.5% margin

Operating Income

$88M6.7% margin

Net Income

$94M7.2% margin

EPS (Diluted)

$0.84

QoQ Revenue Growth

+17.7%

Cash Flow

Operating Cash Flow

$264M

Free Cash Flow

$200M

Stock-Based Comp.

$151M

Balance Sheet

Total Assets

$6.3B

Total Liabilities

$2.5B

Stockholders' Equity

$3.8B

Cash & Equivalents

$2.8B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.3B	$929M	+41.6%
Gross Profit	$1.2B	$791M	+45.5%
Operating Income	$88M	-$107M	+182.0%
Net Income	$94M	-$120M	+178.3%

Revenue Segments

Product

$1.7B99%

Collaboration

$13M1%

Geographic Segments

UNITED STATES

$694M53%

CHINA

$433M33%

Europe

$152M12%

All Other Countries Except China And United States Of America

$36M3%